Targeting the bone marrow microenvironment
Unprecedented advances in multiple myeloma (MM) therapy during the last 15 years are predominantly based on our increasing understanding of the pathophysiologic role of the bone marrow (BM) microenvironment. Indeed, new treatment paradigms, which incorporate thalidomide, immunomodulatory drugs (IMiD...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Chapter/Article |
| Language: | English |
| Published: |
02 October 2016
|
| In: |
Plasma cell dyscrasias
Year: 2016, Pages: 63-102 |
| DOI: | 10.1007/978-3-319-40320-5_6 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/978-3-319-40320-5_6
|
| Author Notes: | Michele Moschetta, Yawara Kawano, Klaus Podar |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1745911073 | ||
| 003 | DE-627 | ||
| 005 | 20230426075021.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210128s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/978-3-319-40320-5_6 |2 doi | |
| 035 | |a (DE-627)1745911073 | ||
| 035 | |a (DE-599)KXP1745911073 | ||
| 035 | |a (OCoLC)1341389885 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Moschetta, Michele |e VerfasserIn |0 (DE-588)1225892287 |0 (DE-627)1745910115 |4 aut | |
| 245 | 1 | 0 | |a Targeting the bone marrow microenvironment |c Michele Moschetta, Yawara Kawano, Klaus Podar |
| 264 | 1 | |c 02 October 2016 | |
| 300 | |a 40 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 28.01.2021 | ||
| 520 | |a Unprecedented advances in multiple myeloma (MM) therapy during the last 15 years are predominantly based on our increasing understanding of the pathophysiologic role of the bone marrow (BM) microenvironment. Indeed, new treatment paradigms, which incorporate thalidomide, immunomodulatory drugs (IMiDs), and proteasome inhibitors, target the tumor cell as well as its BM microenvironment. Ongoing translational research aims to understand in more detail how disordered BM-niche functions contribute to MM pathogenesis and to identify additional derived targeting agents. One of the most exciting advances in the field of MM treatment is the emergence of immune therapies including elotuzumab, daratumumab, the immune checkpoint inhibitors, Bispecific T-cell engagers (BiTes), and Chimeric antigen receptor (CAR)-T cells. This chapter will review our knowledge on the pathophysiology of the BM microenvironment and discuss derived novel agents that hold promise to further improve outcome in MM. | ||
| 650 | 4 | |a BiTEs | |
| 650 | 4 | |a Bone marrow | |
| 650 | 4 | |a Bone marrow microenvironment | |
| 650 | 4 | |a CAR-T cells | |
| 650 | 4 | |a Immune checkpoint inhibition | |
| 700 | 1 | |a Kawano, Yawara |e VerfasserIn |0 (DE-588)1225892562 |0 (DE-627)1745910905 |4 aut | |
| 700 | 1 | |a Podar, Klaus |e VerfasserIn |0 (DE-588)1058672169 |0 (DE-627)797396594 |0 (DE-576)414826795 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Plasma cell dyscrasias |d Cham : Springer, 2016 |g (2016), Seite 63-102 |h Online-Ressource (VI, 361 p. 9 illus., 7 illus. in color, online resource) |w (DE-627)1653632623 |w (DE-576)47936771X |z 9783319403205 |7 nnam |a Targeting the bone marrow microenvironment |
| 773 | 1 | 8 | |g year:2016 |g pages:63-102 |g extent:40 |a Targeting the bone marrow microenvironment |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-319-40320-5_6 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210128 | ||
| 993 | |a BookComponentPart | ||
| 994 | |a 2016 | ||
| 998 | |g 1058672169 |a Podar, Klaus |m 1058672169:Podar, Klaus |d 50000 |e 50000PP1058672169 |k 0/50000/ |p 3 |y j | ||
| 999 | |a KXP-PPN1745911073 |e 3843687730 | ||
| BIB | |a Y | ||
| JSO | |a {"person":[{"family":"Moschetta","roleDisplay":"VerfasserIn","display":"Moschetta, Michele","given":"Michele","role":"aut"},{"family":"Kawano","roleDisplay":"VerfasserIn","display":"Kawano, Yawara","given":"Yawara","role":"aut"},{"role":"aut","family":"Podar","display":"Podar, Klaus","roleDisplay":"VerfasserIn","given":"Klaus"}],"type":{"bibl":"chapter","media":"Online-Ressource"},"title":[{"title_sort":"Targeting the bone marrow microenvironment","title":"Targeting the bone marrow microenvironment"}],"recId":"1745911073","id":{"doi":["10.1007/978-3-319-40320-5_6"],"eki":["1745911073"]},"name":{"displayForm":["Michele Moschetta, Yawara Kawano, Klaus Podar"]},"note":["Gesehen am 28.01.2021"],"physDesc":[{"extent":"40 S."}],"relHost":[{"id":{"isbn":["9783319403205"],"eki":["1653632623"],"doi":["10.1007/978-3-319-40320-5"]},"recId":"1653632623","name":{"displayForm":["edited by Aldo M. Roccaro, Irene M. Ghobrial"]},"type":{"media":"Online-Ressource","bibl":"edited-book"},"part":{"pages":"63-102","year":"2016","extent":"40","text":"(2016), Seite 63-102"},"person":[{"family":"Roccaro","display":"Roccaro, Aldo M.","roleDisplay":"Hrsg.","given":"Aldo M.","role":"edt"},{"given":"Irene M.","roleDisplay":"Hrsg.","display":"Ghobrial, Irene M.","family":"Ghobrial","role":"edt"}],"relMultPart":[{"dispAlt":"Cancer treatment and research","origin":[{"dateIssuedDisp":"1998-","publisherPlace":"New York, NY ; [Berlin ; Heidelberg] ; Boston, Mass. ; Dordrecht ; London","publisher":"Springer ; Springer ; Kluwer","dateIssuedKey":"1998"}],"disp":"Cancer Treatment and Research","language":["eng"],"note":["Gesehen am 30.10.13"],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["Nachgewiesen 96.1998 -"],"id":{"issn":["2509-8497"],"zdb":["2389301-1"],"eki":["54600704X"]},"recId":"54600704X","title":[{"title_sort":"Cancer treatment and research","title":"Cancer treatment and research"}],"type":{"bibl":"serial","media":"Online-Ressource"},"part":{"number":["169"],"number_sort":["169"]}}],"title":[{"title":"Plasma cell dyscrasias","title_sort":"Plasma cell dyscrasias"}],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"2016","publisherPlace":"Cham","publisher":"Springer"}],"physDesc":[{"extent":"Online-Ressource (VI, 361 p. 9 illus., 7 illus. in color, online resource)"}],"language":["eng"],"disp":"Targeting the bone marrow microenvironmentPlasma cell dyscrasias"}],"language":["eng"],"origin":[{"dateIssuedDisp":"02 October 2016","dateIssuedKey":"2016"}]} | ||
| SRT | |a MOSCHETTAMTARGETINGT0220 | ||